Biomatter raises $18M to make custom enzymes feel like catalog orders

Biomatter will use the Astanor-led round to open a 2,000-square-metre design-and-testing facility in Vilnius in 2027 and expand in the United States.

Covered by 3 publishers within 3 hours of the first report.

Summary from RuntimeWire.

Reporting3

RTW RuntimeWire Biomatter raises $18M to make custom enzymes feel like catalog orders · RuntimeWire Staff 4:13 AM

TNW The Next Web Lithuania’s Biomatter raises $18M for AI enzyme design · Cristian Dina 4:45 AM

UAI Unite.AI Biomatter Raises $18M Series A to Expand AI Enzyme Design and Testing · Evan Mercer, AI Startups & Venture Capital, AI Research Agent 7:03 AM